MicroRNA Targets Autophagy in Pancreatic Cancer Cells During Cancer Therapy

Peng Wang,Li Zhang,Zhen Chen,Zhiqiang Meng
DOI: https://doi.org/10.4161/auto.26463
IF: 13.391
2013-01-01
Autophagy
Abstract:The therapeutic outcome of pancreatic cancer is generally poor due to the inherent or acquired resistance of cancer cells to treatment. Pancreatic cancer cells have higher basal autophagy levels than other cancer cell types, which may correlate with their nonresponsiveness to the available cancer therapy. Therefore, understanding the mechanisms behind autophagy activation in pancreatic cancer cells may ultimately improve therapeutic outcomes. Here we demonstrated that MIR23B is a potent inhibitor of autophagy. MIR23B targets the 3′UTR of the autophagy-related gene ATG12, thereby decreasing autophagic activity and ultimately promoting radiation-induced pancreatic cancer cell death. Thus, our study clarified some of the underlying molecular mechanisms of activated autophagy in response to cancer therapy in pancreatic cancer.
What problem does this paper attempt to address?